Milestone Pharmaceuticals (MIST) Market Value

Corporate emblem and logo of Milestone Pharmaceuticals Inc. (MIST)

Milestone Pharmaceuticals (MIST) is developing treatments for tachycardia, leveraging unique patents and support within US medical circles under strict FDA supervision. Business success depends on the registration of a new spray and the acceptance of the drug by physicians. Current market capitalization stands at 0.08, and the price indicator on the chart highlights an investment plateau stage due to high product launch costs.

MIST (milestonepharma.com) Market Value history from 07/04/2022 to 11/11/2026

MIST (Milestone Pharmaceuticals Inc): analytical breakdowns and indicator data

- current price and projected stock value:
Stock Price Milestone Pharmaceuticals Inc.|MIST - Analyst Median Target
- market capitalization details:
Market Value Milestone Pharmaceuticals Inc|MIST - Company Buyout Price
- book value of equity indicators:
Accounting Value per Share Milestone Pharmaceuticals|MIST - Total Net Assets|Market Capitalization to Book Value Ratio milestonepharma.com|MIST - Aggregate Asset Value
- company liabilities and liquidity data:
Total Debt to Capital Milestone Pharmaceuticals|MIST - Long-Term Liabilities to Capital|Short-Term Debt to Capital Milestone Pharmaceuticals|MIST - Company Aggregate Debts|Debt to Book Capitalization Ratio Milestone Pharmaceuticals Inc|MIST - Company Long-Term Loans and Borrowings|Company Current Liabilities Milestone Pharmaceuticals|Quick Liquidity milestonepharma.com
- net income and valuation multiples indicators:
MIST - Net Income|Projected Future Earnings Milestone Pharmaceuticals|MIST - Business Payback Period|Future Price to Earnings Milestone Pharma|MIST - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Milestone Pharmaceuticals Inc|MIST - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Milestone Pharmaceuticals|MIST - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months milestonepharma.com|MIST - Net earnings per one share growth for the current year|Net earnings per share growth forecast for next year Milestone Pharmaceuticals
Fundamental company analysis:MIST (Milestone Pharmaceuticals Inc.)
Product sample of Milestone Pharmaceuticals Inc

Investors assess systemic risks through the lens of asset market value. The strategy of Milestone Pharmaceuticals (MIST) to outsource production and clinical trials to external partners reduces capital expenditures. The total value of all shares, reflected in the issuer's market capitalization, measures market confidence in this model. This indicator determines the scale of the business relative to the industry. The stability of this metric confirms the financial resilience of Milestone Pharmaceuticals (MIST) despite limited potential for explosive growth.

Key competitors

Market Capitalization REGN (Regeneron)|Market Capitalization iRhythm Technologies, Inc. (IRTC)|LNTH - Market Value|Market Capitalization Mineralys Corp MLYS|HTFL (HeartFlow Medical) - Market Valuation|KMTS: Market Value|ESPR (Esperion) - Market Capitalization|AMRN: Market Value|Market Capitalization AVR|TNYA - Market Value|Market Capitalization CVRX (CVRx, Inc.)|Market Capitalization Cardiol Therapeutics Inc CRDL|BEAT - Market Value|Market Value TENX (Tenax Therapeutics Inc.)|ADGM (Adagio Medical Holdings Inc.) - Market Valuation|BCDA: Market Value|Market Value Catheter Precision|Market Valuation ARCA Bio (ABIO)|Market Capitalization ACST|Market Capitalization Aerovate Therapeutics Inc.|Market Value Verve Therapeutics, Inc. VERV|Windtree Therapeutics Inc. - Market Value